B. Riley Wealth Advisors’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

B. Riley Wealth Advisors’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,504	Closed	-$11K	–	871
2019 Q2	$11K	Sell	1,504 -685	-31%	-$5.87K	﹤0.01%	789
2019 Q1	$18K	Sell	2,189 -300	-12%	-$3.1K	﹤0.01%	736
2018 Q4	$40K	Sell	2,489 -30,135	-92%	-$663K	0.01%	652
2018 Q3	$1.08M	Buy	32,624 +1,098	+3%	+$28.2K	0.13%	176
2018 Q2	$713K	Buy	31,526 +7,580	+32%	+$180K	0.09%	234
2018 Q1	$695K	Buy	23,946 +13,945	+139%	+$408K	0.1%	225
2017 Q4	$280K	Buy	+10,001	New	+$310K	0.04%	476

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XSC

X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

B. Riley Wealth Advisors's AVEO Position: Q3 2019 in Review

B. Riley Wealth Advisors sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2019, closing a stake of 1,504 shares — an estimated $11K sold.

B. Riley Wealth Advisors first reported a position in AVEO in Q4 2017 and held it in 7 quarters. The position peaked at $1.08M in Q3 2018. 59 funds tracked by Wall St. Rank hold AVEO as of Q3 2019.

B. Riley Wealth Advisors reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
B. Riley Wealth Advisors sold 1,504 AVEO Pharmaceuticals, Inc. shares in Q3 2019, an estimated $11K.
B. Riley Wealth Advisors first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2017 and held it in 7 quarters.
B. Riley Wealth Advisors's AVEO Pharmaceuticals, Inc. position peaked at $1.08M in Q3 2018.
59 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2019.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.